Lipigon Pharmaceuticals
Manufacturing · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Tvistevägen 48, Umea, Vaesterbotten, 907...Phone Number
+46 705781768Website
www.lipigon.seRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Lipigon Pharmaceuticals
Lipigon Pharmaceuticals AB specializes in developing innovative treatments for dyslipidemia, particularly focusing on high blood fats, which are a major risk factor for cardiovascular diseases. Their lead project, Lipisense, is currently in clinical phases and aims to effectively lower triglyceride levels in patients. The company targets a global market with millions of patients suffering from elevated blood fats, particularly in major markets such as the USA, Japan, and several European countries. Lipigon's vision is to improve and extend the lives of patients affected by conditions related to high blood fats.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Lipigon Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Lipigon Pharmaceuticals recently announced quarterly report
Check out if Lipigon Pharmaceuticals is spiking on competitors!
Check if Lipigon Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Lipigon Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Lipigon Pharmaceuticals has new funding data
Click to see if Lipigon Pharmaceuticals had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Lipigon Pharmaceuticals
Product Launch: Get notified when Lipigon Pharmaceuticals launches new products
Recommended Actions
Reach out to Masked Content who joined Lipigon Pharmaceuticals as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Lipigon Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Lipigon Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Lipigon Pharmaceuticals.
Lipigon Pharmaceuticals Tech Stack
A closer look at the technologies used by Lipigon Pharmaceuticals
Lipigon Pharmaceuticals News & Media
Lipigon Expands Collaboration With HitGen by Selecting Second Target
CHENGDU, China--(BUSINESS WIRE)--Lipigon Pharmaceuticals AB (”Lipigon”), developer of therapeutics for lipid-related diseases, today announced that the company has expanded its agreement with the Shanghai STAR listed company HitGen Inc. (”HitGen”) to include a second novel target. With joint efforts, the aim is to develop a treatment for cardiometabolic disease. Lipigon and HitGen have been collaborating on developing molecules enhancing lipoprotein lipase (“LPL”) activity since May 2020, with
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Lipigon Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Lipigon Pharmaceuticals AB specializes in developing innovative treatments for dyslipidemia, particularly focusing on high blood fats, which are a major risk factor for cardiovascular diseases. Their lead project, Lipisense, is currently in clinical phases and aims to effectively lower triglyceride levels in patients. The company targets a global m... Read More
